Two participants can report similar symptoms and describe different limits in their daily lives. A German analysis followed people who had been hospitalised with COVID-19 and collected both kinds of information. The results provide a concrete example of why the denominator belongs alongside every percentage, especially when some follow-up data are missing.
- The paper’s Results list 473 people with a calculable symptom score at three months. Of them, 361 met the study’s threshold for at least mild post-COVID condition.
- The 156 people with both symptoms at that level and participation limits made up 43.2% of the 361 and 33.0% of the 473.
- Figure 3 shows that later status could be missing. In one severe subgroup of 29 people with early participation limits, 10 lacked a later participation result.
- Paper date
- 21 November 2026
- Setting
- Two German cohorts of hospitalised adults
- Results denominator at three months
- 473 with computable symptom scores
- Joint count at three months
- 156 with both indicators
Original publication: 21 Nov 2026 · The date above refers to this brief.
Later participation status for 29 people with early limits and severe symptoms
people
Find the people behind the three-month percentages
473 scoreable assessments
A symptom score was computable at three months for this group.
361 at least mild
This subgroup reached the study’s symptom threshold.
156 with both measures
These people also met the participation limitation threshold.
The questions covered symptoms and participation
The authors combined follow-up data from two cohorts and selected adults who had been hospitalised during the acute illness. The symptom score draws on the symptoms reported and how long they lasted. A separate set of questions asks about activities with family and friends, leisure and usual work, including work at home. The distinction matters because a symptom count can describe illness burden while leaving the extent of everyday disruption uncertain.
Source 1 ↗Source 2 ↗Follow the numerator through two denominators
At the three-month assessment, the Results report 473 people with enough information for a symptom score. Of those, 361 scored at least mild on the study scale. Among those 361, 156 also reported limitations that met the study’s participation threshold. The first calculation, 156 divided by 361, asks how often participation limits appeared among people who met the symptom threshold. The second, 156 divided by 473, asks how often both measures were present among people with a calculable symptom score. Both use the same 156 people and the same visit.
Source 1 ↗Read missing follow-up as an outcome of data collection
Figure 3 follows groups from three to 12 months. The panel for severe symptoms contains a branch for 29 people who had participation limits at three months. Of those, 16 had a recorded limit at 12 months, three recorded no limit and ten had missing data. Among the 19 with a known later answer, 16 of 19 is 84.2%. Across the original branch, 16 of 29 is the 55.2% with documented limitations at the second visit. The ten missing results explain the gap between the two calculations.
Source 1 ↗What a stronger follow-up could report
A study could list how many participants remained eligible, completed each questionnaire and had an evaluable answer at every time point. It could also compare baseline information for people with and without missing follow-up. Those details would give readers a better basis for judging changes over time. The cohort results apply to a selected group of adults who were hospitalised, and the participation measure describes people’s own reports for the activities asked about.
Source 1 ↗Keep missing data in view when reading percentages
Publisher full article, including the inclusion flowchart, Results and Figure 3. The abstract and body give different headline enrolment counts. The three-month percentages in this article use the explicitly counted Results subgroups.
01What changes between 43.2% and 33.0%?
- What was observed
- Both use 156 people, divided by 361 or 473.
- Where the conclusion stops
- The denominators define separate questions at the same visit.
Source 1 · Results, Post-COVID condition and activity and participation impairment
02What happened to the severe subgroup at the later visit?
- What was observed
- The branch lists 16 with participation limits, 3 without and 10 missing at 12 months.
- Where the conclusion stops
- The chart can separate documented status from unobserved status, which matters for interpreting apparent improvement.
Source 1 · Figure 3D
Numbers you can inspect
| Measure | Value & unit | Origin & method |
|---|---|---|
| Computable symptom scores at three months | 473 people | Reported Results count for the scoreable group. Source 1 · Results, Post-COVID condition and activity and participation impairment |
| At least mild on the symptom score | 361 people | Reported Subset of the 473 with a score. Source 1 · Results, Post-COVID condition and activity and participation impairment |
| Both symptom and participation thresholds | 156 people | Reported Joint count at the three-month visit. Source 1 · Results, Post-COVID condition and activity and participation impairment |
| Joint count as share of people with at least mild symptoms | 43.2 percent | Calculated Divide 156 by 361 and multiply by 100. Source 1 · Results, Post-COVID condition and activity and participation impairment |
| Joint count as share of the scoreable group | 33 percent | Calculated Divide 156 by 473 and multiply by 100. Source 1 · Results, Post-COVID condition and activity and participation impairment |
| Prior severe subgroup with a later report of limits | 16 people | Reported Documented participation limits at 12 months. Source 1 · Figure 3D |
| Prior severe subgroup with a later report of no limits | 3 people | Reported Documented no participation limits at 12 months. Source 1 · Figure 3D |
| Prior severe subgroup with later status missing | 10 people | Reported Missing 12-month participation status. Source 1 · Figure 3D |
| Share reporting a limit among those observed later | 84.2 percent | Calculated Divide 16 by the 19 with later status, then multiply by 100. Source 1 · Figure 3D |
| Share with a documented later limit among the original branch | 55.2 percent | Calculated Divide 16 by all 29 in the original branch, then multiply by 100. Source 1 · Figure 3D |
Compare the actual experiments
These studies answer different questions. Read the unit and endpoint before comparing results.
| Study | Unit & setting | Readout | Interpretation boundary |
|---|---|---|---|
| Earlier symptom score study and the new participation measure Source 2 · Appel et al., Abstract and Results | Adults assessed at follow-up in NAPKON cohorts | Symptom severity and difficulty in daily roles | Work, family and leisure questions add detail beyond the number and duration of symptoms. |
| Known later status and missing later status Source 1 · Figure 3D | Severe-symptom group with participation limits at three months | Participation status at the 12-month visit | Carry the ten missing observations when reading any percentage from this subgroup. |
The export includes claims, available numbers, methods and source locations. It contains our reading notes and published summaries; it is not raw participant data or an independent reanalysis.
Evidence update · 22 Nov 2026
First publication. Any calculations in this brief use reported figures. The reading notes identify possible follow-up questions. AI source check; no human editorial or clinical review.
Same joint count, different questions
| Group | Calculated share or count | Question answered |
|---|---|---|
| Among people meeting the symptom threshold | 156 ÷ 361 = 43.2% | How often did this group also report limits in participation? |
| Among people with a computable symptom score | 156 ÷ 473 = 33.0% | How often were both criteria documented in the scoreable group? |
| Later status in one severe subgroup | 16 with limits, 3 without, 10 missing | Twenty-nine had limits at three months. Figure 3D tracks this branch. |
Press-News calculations from the Results. The last row refers to one Figure 3D branch and a later visit.
Your questions, answered
Why are both 43.2% and 33.0% correct?
Both calculations start with 156 people. They divide by different groups, either 361 with at least mild symptoms or 473 with a computable symptom score.
What did the participation questions cover?
They asked about usual work, leisure and activities with family and friends, including work at home.
How did the study record people without a later answer?
The trajectory figure has a separate category for missing later data. The chart below uses that category in the severe subgroup.
Can the percentages describe everyone after COVID-19?
They describe analysed adult hospital survivors in the selected German cohorts. A community estimate would need a sample drawn from that target population.
Limits of this interpretation
- The inclusion flowchart reports 654 pooled participants, while the abstract gives 655 in its three-month summary. The paired percentages here use the 473, 361 and 156 counts reported together in the Results.
- The sample comes from two German cohorts and excludes people with outpatient treatment alone.
- Some patients had missing later participation data. Descriptive results and observed follow-up counts depend on who answered.
Sources & transparency
- Nürnberger, Steinmetz, Appel et al. (2026) — Function, activity and participation limitations in patients with post-COVID condition
Publisher full article, including the inclusion flowchart, Results and Figure 3. The abstract and body give different headline enrolment counts. The three-month percentages in this article use the explicitly counted Results subgroups. · Accessed 22 Nov 2026
DOI: 10.1038/s41598-026-81336-w - Appel et al. (2024) — Definition of post-COVID syndrome using a symptom-based post-COVID score
Author abstract of the earlier cohort study. Checked how the symptom score was applied and related to reported quality of life. · Accessed 22 Nov 2026
DOI: 10.1007/s15010-024-02226-9
Prepared and source-checked with AI for Press-news Team. The source notes identify the material available during preparation. The article received no human editorial or clinical review. The source list supports the reported results and the calculations shown.
Source check: AI source check — primary research and stated source limits
Clinical review: Not applicable to this educational guide
Suggest a correction